首页> 外文OA文献 >Combination of chemotherapy and gefitinib as first-line treatment for patients with advanced lung adenocarcinoma and sensitive EGFR mutations: A randomized controlled trial

【2h】

Combination of chemotherapy and gefitinib as first-line treatment for patients with advanced lung adenocarcinoma and sensitive EGFR mutations: A randomized controlled trial

机译：化疗和吉非替尼的组合作为晚期肺腺癌患者的一线治疗和敏感EGFR突变：随机对照试验

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Baohui Han; Bo Jin; Tianqing Chu; Yanjie Niu; Yu Dong; Jianlin Xu; Aiqing Gu; Hua Zhong; Huimin Wang; Xueyan Zhang; Chunlei Shi; Yanwei Zhang; Wei Zhang; Yuqing Lou; Lei Zhu; Jun Pei;
展开▼
作者单位

展开▼
年度 2017
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Combination of chemotherapy and gefitinib as first-line treatment for patients with advanced lung adenocarcinoma and sensitive EGFR mutations: A randomized controlled trial [J] . Han Baohui, Jin Bo, Chu Tianqing, International Journal of Cancer =: Journal International du Cancer . 2017,第6期

机译：化疗和吉非替尼的组合作为晚期肺腺癌患者的一线治疗和敏感EGFR突变：随机对照试验
2. Combination of icotinib and chemotherapy as first-line treatment for advanced lung adenocarcinoma in patients with sensitive EGFR mutations: A randomized controlled study [J] . Xu Lisheng, Qi Qian, Zhang Yan, Lung cancer: Journal of the International Association for the Study of Lung Cancer . 2019,第期

机译：icotinib和化疗的组合作为敏感EGFR突变患者晚期肺腺癌的第一线治疗：随机对照研究
3. Efficacy of platinum combination chemotherapy after first-line gefitinib treatment in non-small cell lung cancer patients harboring sensitive EGFR mutations [J] . Masuda T., Imai H., Kuwako T., Clinical & translational oncology : . 2015,第9期

机译：吉非替尼一线治疗后铂类联合化疗对具有敏感EGFR突变的非小细胞肺癌患者的疗效
4. EGFR Mutations in Lung Adenocarcinoma: Correlation with F-18 FDG PET/CT [C] . Jinyoung Yoo, Sonya Youngju Park International Molecular Medicine Tri-Conference. . 2016

机译：肺腺癌的EGFR突变：与F-18 FDG PET / CT的相关性
5. A Phase II, Randomized, Double-Blind, Placebo-Controlled Trial of Fish Oil (Eicosapentaenoic Acid and Docosahexaenoic Acid) on Lung and Systemic Inflammation in Patients with Acute Lung Injury. [D] . Stapleton, Renee Doney. 2010

机译：鱼油（二十碳五烯酸和二十二碳六烯酸）对急性肺损伤患者的肺和全身炎症的II期，随机，双盲，安慰剂对照试验。
6. First-Generation EGFR-TKI Plus Chemotherapy Versus EGFR-TKI Alone as First-Line Treatment in Advanced NSCLC With EGFR Activating Mutation: A Systematic Review and Meta-Analysis of Randomized Controlled Trials [O] . Qiang Wu, Wuxia Luo, Wen Li, 2021

机译：第一代EGFR-TKI加上化疗与EGFR-TKI单独作为高级NSCLC的一线治疗具有EGFR激活突变：随机对照试验的系统评价和荟萃分析
7. PCN4 Sequential Combination of Chemotherapy With Egfr-Tki As The First-Line Treatment for Unselected Patients With Advanced Non-Small Cell Lung Cancer: Systematic Review of Randomized Controlled Trials [O] . Li X, Tang X, Li Y, 2014

机译：PCN4序贯化疗联合Egfr-Tki作为未选患者的晚期非小细胞肺癌的一线治疗：随机对照试验的系统评价

Combination of chemotherapy and gefitinib as first-line treatment for patients with advanced lung adenocarcinoma and sensitive EGFR mutations: A randomized controlled trial

著录项

引文网络

相似文献

相关主题

期刊订阅